Withdrawal Seizures Seen In the Setting of Synthetic Cannabinoid Abuse☆
Christopher S. Sampson

,x
, MDChristopher S. Sampson
Search for articles by this author
Correspondence
- Corresponding author. One Hospital Drive, DC 029.1, Columbia, MO 65212.

x
Christopher S. Sampson
Search for articles by this author
Correspondence
- Corresponding author. One Hospital Drive, DC 029.1, Columbia, MO 65212.

Starr-Mar’ee Bedy, PharmD, BCPS
, Terry Carlisle, PA-C
Department of Emergency Medicine, University of Missouri-Columbia, Columbia, MO
Article Info
Publication History
Published Online: March 15, 2015Accepted: March 7, 2015; Received: March 6, 2015;
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.
The recent rise in the abuse of synthetic cannabinoid receptor agonists (Spice, K2) has led to an increase of patients presenting to emergency departments (EDs) with complications stemming from their abuse. We present a case of withdrawal seizures seen in a chronic abuser of these herbal mixtures who stopped using them abruptly. Seizures have been reported in the literature in the setting of abuse, but not during withdrawal [1].
To access this article, please choose from the options below
Purchase access to this article
Claim Access
If you are a current subscriber with Society Membership or an Account Number, claim your access now.
Subscribe to this title
Purchase a subscription to gain access to this and all other articles in this journal.
Institutional Access
Visit ScienceDirect to see if you have access via your institution.
☆The authors declare no conflicts of interest.
© 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
Access this article on
Visit ScienceDirect to see if you have access via your institution.
Article Tools
Related Articles
Searching for related articles..
